Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform NeurofibromasEva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Neuro-Oncology|April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidityAndrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
American Journal of Medical Genetics. Part A|January 9, 2020
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathiesAndrea M Gross, Megan Frone, Karen W Gripp, et al.
Communications Biology|October 11, 2018
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1Sara H Isakson, Anthony E Rizzardi, Alexander W Coutts, et al.
Cancer Epidemiology|January 23, 2025
Risk of carcinomas among children and adolescents with birth defectsJeremy M Schraw, Ji Yun Tark, Tania A Desrosiers, et al.
Neuro-Oncology|April 8, 2023
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patientsMyrsini Ioakeim-Ioannidou, Andrzej Niemierko, Daniel W Kim, et al.
Cancer Research Communications|November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 ParticipantsShadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2016
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer ResearchWendy Chang, Andrew S Brohl, Rajesh Patidar, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform NeurofibromasEva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Neuro-Oncology|April 25, 2022
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidityAndrea M Gross, Brittany Glassberg, Pamela L Wolters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
American Journal of Medical Genetics. Part A|January 9, 2020
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathiesAndrea M Gross, Megan Frone, Karen W Gripp, et al.
Communications Biology|October 11, 2018
Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1Sara H Isakson, Anthony E Rizzardi, Alexander W Coutts, et al.
Cancer Epidemiology|January 23, 2025
Risk of carcinomas among children and adolescents with birth defectsJeremy M Schraw, Ji Yun Tark, Tania A Desrosiers, et al.
Neuro-Oncology|April 8, 2023
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patientsMyrsini Ioakeim-Ioannidou, Andrzej Niemierko, Daniel W Kim, et al.
Cancer Research Communications|November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 ParticipantsShadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2016
MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer ResearchWendy Chang, Andrew S Brohl, Rajesh Patidar, et al.
Pageof 21